Teva offers co-pay program for Gleevec generic
NORTH WALES, Pa. — Teva Pharmaceuticals USA has launched a U.S. prescription co-payment assistance program in the U.S. for its imatinib mesylate tablets, a cancer treatment. People who meet certain requirements are eligible for the program and may pay as little as $0 out of pocket, with a maximum benefit of up to $700 per
